Risk stratification and prevention in chronic coronary artery disease: Use of a novel prognostic and computer-based clinical decision support system in a large primary managed-care group practice

Disease Management

Volumn 5, Issue 4, 2002, Pages 197-213

  Levin, Richard I ^a,d   Koenig, Karen L ^b   Corder, Michael P ^c   Bhalla, Narinder P ^a   Rosenzweig, Barry P ^a   Recht, Phoebe A ^a  

^a Cardiology Section   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Bakersfield Family Medical Group   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; AMBULATORY MONITORING; ANGINA PECTORIS; ARTICLE; COMPUTER SYSTEM; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST OF ILLNESS; FEMALE; HEART CATHETERIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MORBIDITY; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0036975249     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/10935070260474976     Document Type: Article

References (79)

1. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. Circulation 1999;99:2829-2848.
2. Bodenheimer MM. Risk stratification in coronary disease: a contrary viewpoint. Ann Intern Med 1992;116: 927-936.
3. Krone R, Gregory J, Freedland K, et al. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of stable coronary heart disease. J Am Coll Cardiol 1994;24:1274-1281.
4. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-468.
5. Solomon AJ, Gersh BJ. Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials. Ann Intern Med 1998;128:216-223.
6. Parker JD. Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials. Eur Heart J 1998;19:115-119.
7. Pepine CJ, Levin RI. Myocardial ischemia as a target for treatment of patients with chronic coronary artery disease. ACC Curr J Rev 1998;7:23-27.
8. Dartmouth Medical School. Center for the Evaluative Clinical Sciences. The quality of health care in the United States: a report on the medicare program; the Dartmouth atlas of health care 1999. Chicago: AHA Press, 1999.
9. Verrilli D, Welch HG. The impact of diagnostic testing on therapeutic interventions. JAMA 1996;275: 1189-1191.
10. Wennberg DE, Kellett MA, Dickens JD Jr, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA 1996;275:1161-1164.
11. Dartmouth Medical School. Center for the Evaluative Clinical Sciences. The Dartmouth atlas of health care in the United States. Chicago: American Hospital Publishing, 1996.
12. Giles WH, Anda RF, Jones DH, Serdula MK, Merritt RK, DeStefano F. Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA 1993;269:1133-1138.
13. Vogel RA. Risk factor intervention and coronary artery disease: clinical strategies. Coron Artery Dis 1995;6:466-471.
14. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes. Circulation 1995;92:2841-2847.
15. Grundy SM, Balady GJ, Criqui MH, et al. When to start cholesterol-lowering therapy in patients with coronary heart disease. Circulation 1997;95:1683-1685.
16. Gottlieb SS, McCarter RJ, Vogel RA. Effect of betablockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-497.
17. Sueta CA, Chowdhury M, Boccuzzi SJ, et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 1999;83:1303-1307.
18. Johnston ME, Langton KB, Haynes RB, Mathieu A. Effects of computer-based clinical decision support systems on clinicial performance and patient outcome. A critical appraisal of research. Ann Intern Med 1994;120:135-142.
19. Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision systems on physician performance and patient outcomes: a systematic review. JAMA 1998;280:1339-1346.
20. Levin RI, Corder MP, Bhalla NP, Koenig KL, Kraf TJ for the Ohms|Cad Investigators. A novel telecommunications system approach for coronary risk stratification, risk factor modification and prevention: outcomes at one year [abstract]. Circulation 1997;96:I-66.
21. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;296:320-331.
22. Pearson T, Rapaport E, Criqui M, et al. Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group. Circulation 1994;90:3125-3133.
23. Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation 1995;92:2-4.
24. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH publication no. 98-4080. Bethesda, MD: National Institutes of Health, 1998.
25. Expert Panel on Detection EaToHBCiA. Summary of the Second Report of the National Cholesterol Education (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
26. Mody FV, Nademanee K. Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relation to prognostic determinants during exercise stress testing and coronary angiography. J Am Coll Cardiol 1988;12:1169-1176.
27. Gottlieb SO, Weisfeldt ML. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 1987;10:756-760.
28. Smith RC, Leung JM, Mangano DT. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. S.P.I. Research Group. Anesthesiology 1991;74:464-473.
29. Mangano DT, Wong MG, London MJ, Tubau JF, Rapp JA, the Study of Perioperative Ischemia (SPI) Research Group. Perioperative myocardial ischemia in patients undergoing noncardiac surgery - II: Incidence and severity during the 1st week after surgery. J Am Coll Cardiol 1991;17:851-857.
30. Parmley WP, Nesto RW, Singh BN, Deanfield J, Gottleib SO, the N-CAP Study Group. Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992;19:1380-1389.
31. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-768.
32. Levin RI, Cohen D, Frisbie W, et al. Potential for realtime processing of the continously monitored electrocardiogram in the detection, quantitation, and intervention of myocardial ischemia. Cardiovasc Clin 1986;4:735-745.
33. Levin RI. Quantitation of transient myocardial ischemia by digital, ambulatory electrocardiography. Am J Cardiol 1988;61:13B-17B.
34. Frisbie WR. A trend detecting algorithm for ST-segment and rate abnormalities. Paper presented at the IEEE Computer Society: Computers in Cardiology; 1988.
35. Weiner DA, Becker LC, Bonow RO. Recognition, pathogenesis and management options in silent coronary artery disease [abstract]. Circulation 1987;75:II-49-II-50.
36. Garrett JS, Botvinick EH, Parmley WW, Chatterjee K. Ambulatory assessment of myocardial ischemia [abstract]. Clin Res 1986;34:302A.
37. Jamal SM, Mitra-Duncan L, Kelly DT, Freedman SB. Validation of a real-time electrocardiographic monitor for detection of myocardial ischemia secondary to coronary artery disease. Am J Cardiol 1987;60:525-527.
38. Barry J, Campbell S, Nabel EG, Mead K, Selwyn AP. Ambulatory monitoring of the digitized electrocardiogram for detection and early warning of transient myocardial ischemia in angina pectoris. Am J Cardiol 1987;60:483-488.
39. Tripostiadis F, Michaelides A, Papdopoulos P, Toutouzas P. A comparative study between the standard and the digitized ECG for the detection of ST changes during exercise testing. Hippocrates 1989;217-221.
40. Imperi GA, Lambert CR, Hill JA, Pepine CJ. Ambulatory ECG (Holter) monitoring in management of acute myocardial ischemia. In: David D, Dreifus LS, Michelson EL, eds. Ambulatory monitoring of the cardiac patient. Philadelphia: Saunders, 1988:7-22.
41. Corder MP, Monaco JL, Levin RI. The introduction of ambulatory electrocardiographic monitoring for the diagnosis and management of myocardial ischemia. Am J Med Qual 1997;12:169-174.
42. Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator. NIH publication no. 791-649. Bethesda, MD: National Institutes of Health, 1979.
43. Randolph AG, Haynes RB, Wyatt JC, Cook DJ, Guyatt GH. Users' guide to the medical literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinical decision support system. JAMA 1999;282:67-74.
44. Resident population estimates of the United States by age and sex: April 1, 1990 to October 1, 1999. Washington DC, U.S. Census Bureau. Population Estimates Program. Statistical Information Staff. Available at: http://www.census.gov/population/estimates/nation. Accessed November 26, 1999.
45. 2000 heart and stroke statistical update. Dallas: American Heart Association, 1999.
46. Dartmouth Medical School. Center for the Evaluative Sciences. The Dartmouth atlas of health care. Chicago: American Hospital Publishing, 1998.
47. Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996;335:1290-1302.
48. Rill V, Brown DL. Practice of coronary angioplasty in California in 1995: comparison to 1989 and impact of coronary stenting. Circulation 1999;99:1-6.
49. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
50. Martin GM, Sprague CA, Epstein CJ. Replicative lifespan of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest 1970;23:86-92.
51. Libby P. Lesion versus lumen [comment]. Nat Med 1995;1:17-18.
52. Fox AC, Levin RI. Ruptured plaques and leaking cells: cost-effectiveness in the diagnosis of acute coronary syndromes. Ann Intern Med 1999;131:968-970.
53. Currie P, Ashby D, Saltissi S. Prognostic significance of transient myocardial ischemia on ambulatory monitoring after acute myocardial infarction. Am J Cardiol 1993;71:773-777.
54. Weiner DA, Ryan TJ, McCabe CH, et al. Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol 1987;59:725-729.
55. Pepine CJ, Sharaf B, Andrews TC, et al. Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. J Am Coll Cardiol 1997;29:1483-1489.
56. Cole JP, Ellestad MH. Significance of chest pain during treadmill exercise: correlation with coronary events. Am J Cardiol 1978;41:227-232.
57. McHenry PL, O'Donnell J, Morris SN, Jordan JJ. The abnormal exercise electrocardiogram in apparently healthy men is predictive of angina pectoris as an initial coronary event in long-term follow-up. Circulation 1984;70:547-551.
58. Weiner DA, Ryan TJ, McCabe CH, et al. Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in three-vessel coronary artery disease: a report from the coronary artery surgery study (CASS) registry. Am J Cardiol 1987;60:262-266.
59. Kotler TS, Diamond GA. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med 1990;113:684-702.
60. American College of Physicians. Efficacy of exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med 1990;113:703-704.
61. Heart and stroke facts: 1999 statistical supplement. Dallas: American Heart Association, 1999.
62. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol 1995;76:570-573.
63. Missed opportunities in preventive counseling for cardiovascular disease - United States 1995. MMWR Morb Mortal Wkly Rep 1998;47:91-95.
64. Rocco MB, Nabel EG, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988;78:877-884.
65. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748-756.
66. Gill JB, Cairns JA, Roberts RS, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996;334:65-70.
67. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up. Circulation 1997;95:2037-2043.
68. Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 1998;129:681-689.
69. Grundy SM, Cleeman JI, Rifkind BM, Kuller LH. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Arch Intern Med 1999;159:1670-1678.
70. Hays JT, Croghan IT, Schroeder DR, et al. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health 1999;89:1701-1707.
71. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
72. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995;75:894-903.
73. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-1146.
74. Day F, Hoang LP, Ouk S, Nagda S, Schriger DL. The impact of a guideline-driven computer charting system on the emergency care of patients with acute low back pain. Proc Annu Symp Comput Appl Med Care 1995;576-580.
75. Gundersen L. The effect of clinical practice guidelines on variations in care. Ann Intern Med 2000;133: 317-318.
76. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study angiographic core laboratory. J Am Coll Cardiol 1997;29:78-84.
77. Goodman SG, Freeman MR, Armstrong PW, Langer A. Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina? Am J Cardiol 1994;73:747-752.
78. Bodenheimer T. Disease management - promises and pitfalls. N Engl J Med 1999;340:1202-1205.
79. Stein JJ. Medicine by numbers [letter; comment]. Arch Intern Med 1998;158:1720, 1723.